Letters
Life after prostate cancer
Time to evaluate focal therapy
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1057 (Published 23 February 2010) Cite this as: BMJ 2010;340:c1057
- Paul Cathcart, academic clinical lecturer in urology1,
- Hashim Uddin Ahmed, MRC research fellow and specialist registrar in urology1,
- Caroline Moore, academic clinical lecturer in urology1,
- Mark Emberton, reader in interventional oncology1
- 1Division of Surgery and Interventional Sciences, University College London and University College Hospital London, London NW1 2BU
- pjcathcart{at}hotmail.com
Smith and colleagues’ findings on quality of life after diagnosis and treatment of localised prostate cancer1 are neither new nor unexpected.2 3
While much resource has gone into refining both radiotherapeutic and surgical approaches to care, the key question is: has increased specification decreased the toxicity of prostate cancer …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.